Testing a Drug’s Disease-Modifying Potential For Frontotemporal Dementia
A Phase 2a clinical trial is underway to test the possible benefits of sodium selenate for people living with frontotemporal dementia. While Alzheimer’s is…
A Phase 2a clinical trial is underway to test the possible benefits of sodium selenate for people living with frontotemporal dementia. While Alzheimer’s is…
Frontotemporal lobar degeneration, also known as frontotemporal dementia (FTD), refers to various disorders that cause cell damage and affect the brain. FTD is the…
Researchers in Florida have pinpointed a protein that contributes to Alzheimer’s biomarker tau protein accumulation in the brain. They argue it may be a…
While scientists remain far from finding a cure for dementia in its many forms, researchers are continuing to make slow-but-steady progress toward identifying potential…
While researchers are looking into new forms of medicinal solutions to dementia, more and more attention is being paid to lifestyle-focused approaches to the…
Scientists are continuing to search for answers to Alzheimer’s disease and other dementias, targeting beta-amyloid and tau protein, inflammation, and genetic factors in research…